Skip to main content
MACROGENICS INC logo

MACROGENICS INC — Investor Relations & Filings

Ticker · MGNX ISIN · US5560991094 LEI · 5493001KJQUA83L8MH79 US Manufacturing
Filings indexed 894 across all filing types
Latest filing 2015-12-22 Director's Dealing
Country US United States of America
Listing US MGNX

About MACROGENICS INC

https://www.macrogenics.com/

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2015-12-22 English
FORM 4
Director's Dealing
2015-12-22 English
FORM 4
Director's Dealing
2015-11-24 English
FORM 4
Director's Dealing
2015-11-17 English
Earnings Release 2015
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 4, 2015, reporting the company's financial and operating results for the period ended September 30, 2015. It specifically states that the full text of the press release announcing these results is attached as Exhibit 99.1. The document is relatively short (2884 characters) and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or substantive financial data itself. According to the rules, such a document is classified as an Earnings Release (ER) since it is the initial announcement of quarterly financial results with key highlights, not a full interim or annual report. The presence of a press release attached and the nature of the filing (8-K) support this classification with high confidence.
2015-11-04 English
FORM 10-Q
Interim / Quarterly Report 9M 2015
2015-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.